Article info

Download PDFPDF

Safety and acceptability of clozapine and risperidone in progressive multiple sclerosis: a phase I, randomised, blinded, placebo-controlled trial

Authors

  1. Correspondence to Professor Anne C La Flamme; anne.laflamme{at}vuw.ac.nz
View Full Text

Citation

La Flamme AC, Abernethy D, Sim D, et al
Safety and acceptability of clozapine and risperidone in progressive multiple sclerosis: a phase I, randomised, blinded, placebo-controlled trial

Publication history

  • Received March 23, 2020
  • Revision received May 28, 2020
  • Accepted June 1, 2020
  • First published July 9, 2020.
Online issue publication 
July 09, 2020

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.